Lymphoma and Pesticides

What causes lymphoma?

The causes of cancer are complex and not altogether known. There are many things to consider: our heredity, viruses, our exposures to toxic substances in the environment (including chemicals that can cause cancer) and other factors. Anyone who could answer this question with certainty would surely win the Nobel Prize in Medicine.

And yet, there is so much we do know. Over the years, many researchers have done studies to see if pesticides cause lymphoma. Although they do not all agree, many scientists believe this is a serious problem.

The report does offer this suggestion:

“Every day you make choices that affect your health. Since there appears to be a relationship between pesticides and lymphoma, then this risk factor may be partially under your control. You can choose whether to make an effort to reduce your exposure to pesticides.”

For more information, read the 60 page Pesticide Research Project at: http://www.lymphomahelp.org/rr_2000.pdf

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap